Methodological Considerations in Evaluating CTRP12 as a Biomarker for In‐Stent Restenosis
Clinical Cardiology · 2026-02 · 49 (2)
DOI: 10.1002/clc.70271 ↗Kurz gefasst
Leserbrief in der Zeitschrift Clinical Cardiology, online erschienen am 02.02.2026. Verfasst von Saleha Khattak und 2 weiteren Autor:innen. Beteiligte Einrichtung: Khyber Girls Medical College, Peshawar, Pakistan. Die Arbeit nennt 5 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Khyber Girls Medical College, Peshawar, Pakistan.
- Ayub Medical College, Abbottabad, Pakistan.
- Nowshera Medical College, Nowshera, Pakistan.
ORCID-Profile: Saleha Khattak, Syed Muhammad Rayyan, Syed Huzaifa Khan
Zitieren
APA
Khattak, S., Rayyan, S. M., & Khan, S. H. (2026). Methodological Considerations in Evaluating CTRP12 as a Biomarker for In‐Stent Restenosis. Clinical Cardiology, 49(2). https://doi.org/10.1002/clc.70271
Vancouver
Khattak S, Rayyan SM, Khan SH. Methodological Considerations in Evaluating CTRP12 as a Biomarker for In‐Stent Restenosis. Clinical Cardiology. 2026;49(2). doi:10.1002/clc.70271
BibTeX
@article{Khattak2026,
author = {Khattak, Saleha and Rayyan, Syed Muhammad and Khan, Syed Huzaifa},
title = {Methodological Considerations in Evaluating CTRP12 as a Biomarker for In‐Stent Restenosis},
journal = {Clinical Cardiology},
year = {2026},
volume = {49},
number = {2},
doi = {10.1002/clc.70271}
}
EUVIMED